Sept 18 (Reuters) - Organon & Co ( OGN ):

* ORGANON TO ACQUIRE DERMAVANT INCLUDING ITS INNOVATIVE

DERMATOLOGIC THERAPY, VTAMA® (TAPINAROF) CREAM, 1%

* ORGANON & CO ( OGN ) - DEAL VALUED AT UP TO $1.2 BILLION

* ORGANON & CO ( OGN ): DEAL TO BE MODESTLY DILUTIVE TO ADJUSTED

EBITDA IN

2025, TURNING ACCRETIVE IN 2026

* ORGANON & CO-FDA REVIEWING SNDA FOR VTAMA CREAM AS

POTENTIAL

TREATMENT FOR AD IN ADULTS & CHILDREN 2 YRS OF AGE &OLDER,WITH

PDUFA ACTION SEES IN Q4

Source text for Eikon:

Further company coverage: